Want to join the conversation?
Pharma major $AGN said it filed a de novo application with the Food and Drug Administration (FDA) for the Oculeve Intranasal Tear Neurostimulator device, which increases tear production upon activation in patients with dry eye disease. De novo application is an alternate pathway to classify novel devices of low to moderate risk.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?